{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:16:18Z","timestamp":1776827778402,"version":"3.51.2"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/jjco\/hyx107","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T11:13:38Z","timestamp":1499426018000},"page":"942-948","source":"Crossref","is-referenced-by-count":5,"title":["Cumulative incidence, risk factors and prognostic impact of venous thromboembolism in Japanese patients with advanced gastric cancer"],"prefix":"10.1093","volume":"47","author":[{"given":"Hiroyuki","family":"Arai","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Chiba Cancer Center, Chiba"},{"name":"Division of Clinical Oncology, St. Marianna University School of Medicine, Kanagawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Hironaka","sequence":"additional","affiliation":[{"name":"Clinical Trial Promotion Department, Chiba Cancer Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Minashi","sequence":"additional","affiliation":[{"name":"Clinical Trial Promotion Department, Chiba Cancer Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamichi","family":"Denda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba Cancer Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Cancer Biostatistics Laboratory Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba Cancer Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"key\n\t\t\t\t2018110607554128500_hyx107C1","author":"International Agency for Research on Cancer"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C2","first-page":"215","article-title":"S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial","volume":"9","author":"Koizumi","year":"2008","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C3","first-page":"141","article-title":"Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-na\u00efve patients with advanced gastric cancer","volume":"26","author":"Yamada","year":"2015","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C4","first-page":"687","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C5","first-page":"3968","article-title":"Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study","volume":"29","author":"Ohtsu","year":"2011","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C6","first-page":"e1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C7","first-page":"1723","article-title":"Trousseau's syndrome: multiple definitions and multiple mechanisms","volume":"110","author":"Varki","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C8","first-page":"715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C9","first-page":"1846","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C10","first-page":"632","article-title":"Thrombolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C11","first-page":"458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C12","first-page":"540","article-title":"The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer","volume":"8","author":"Lee","year":"2010","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C13","first-page":"2339","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C14","first-page":"853","article-title":"Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas","volume":"112","author":"Wahrenbrock","year":"2003","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C15","first-page":"555","article-title":"Chemotherapy induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C16","first-page":"297","article-title":"Risk factors for venous thromboembolicevents in cancer patients","volume":"17","author":"Kroger","year":"2006","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C17","first-page":"3786","article-title":"Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group","volume":"27","author":"Starling","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C18","first-page":"654","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline update 2014","volume":"33","author":"Lyman","year":"2015","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C19","first-page":"3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C20","first-page":"3484","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C21","first-page":"492","article-title":"Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience","volume":"48","author":"Kang","year":"2012","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C22","first-page":"1989","article-title":"The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma","volume":"109","author":"Tetzlaff","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C23","first-page":"1305","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C24","first-page":"S11","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","volume":"123","author":"White","year":"2009","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C25","first-page":"1896","article-title":"Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study","volume":"121","author":"Holst","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C26","first-page":"821","article-title":"Obesity measures and risk of venous thromboembolism and myocardial infarction","volume":"29","author":"Horvei","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C27","first-page":"415","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C28","first-page":"2698","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C29","first-page":"533","article-title":"Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights","volume":"39","author":"Braekkan","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C30","first-page":"849","article-title":"The influence of abdominal pressure on lower extremity venous pressure and hemodynamics: a human in-vivo model simulating the effect of abdominal obesity","volume":"41","author":"Willenberg","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C31","first-page":"664","article-title":"Impact of obesity on venous hemodynamics of the lower limbs","volume":"52","author":"Willenberg","year":"2010","journal-title":"J Vasc Surg"},{"key":"key\n\t\t\t\t2018110607554128500_hyx107C32","first-page":"4902","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/47\/10\/942\/26368819\/hyx107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T12:55:51Z","timestamp":1541508951000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/47\/10\/942\/4056325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,7,31]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyx107","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"value":"0368-2811","type":"print"},{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,7,31]]}}}